Gaurav Aggarwal

J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology

Manufactures pharmaceuticals products

Functions as a College/University

KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements.

Designs, develops and manufactures endovascular devices

IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Asia specializes in expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $15 million. They also takes board seat and controlling shares. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage.

Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million.

Develops therapeutics for gastrointestinal and liver diseases

Provides investment banking services

Operates as a biopharmaceutical company

Patricia Industries invests in companies located in the Nordic region and North America. The firm focuses on a broad range of sectors and industries. It provides financing for buyout capital transactions.

Functions as a College/University

Develops therapeutic drugs to treat kidney diseases